Avondale Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,692
| Closed | -$55.5K | – | 123 |
|
|
2023
Q4 | $55.5K | Sell |
1,692
-5,481
| -76% | -$180K | 0.04% | 78 |
|
|
2023
Q3 | $200K | Hold |
7,173
| – | – | 0.18% | 45 |
|
|
2023
Q2 | $245K | Buy |
7,173
+1,500
| +26% | +$51.1K | 0.21% | 44 |
|
|
2023
Q1 | $171K | Buy |
5,673
+1,000
| +21% | +$30.1K | 0.15% | 47 |
|
|
2022
Q4 | $132K | Hold |
4,673
| – | – | 0.11% | 43 |
|
|
2022
Q3 | $154K | Hold |
4,673
| – | – | 0.17% | 39 |
|
|
2022
Q2 | $147K | Buy |
4,673
+2,500
| +115% | +$78.6K | 0.17% | 40 |
|
|
2022
Q1 | $100K | Hold |
2,173
| – | – | 0.12% | 50 |
|
|
2021
Q4 | $133K | Hold |
2,173
| – | – | 0.13% | 49 |
|
|
2021
Q3 | $162K | Sell |
2,173
-1,000
| -32% | -$74.6K | 0.16% | 49 |
|
|
2021
Q2 | $294K | Buy |
3,173
+1,132
| +55% | +$105K | 0.27% | 39 |
|
|
2021
Q1 | $181K | Buy |
+2,041
| New | +$181K | 0.18% | 43 |
|